
Moderna chief executive Stephane Bancel on Thursday shrugged off the Biden administration’s support for suspending patents for coronavirus vaccines, saying drug firms in other countries would struggle to mass-produce a rival to the blockbuster vaccine that has made his company a household name.
Speaking during a first-quarter earnings call, the head of the Cambridge biotech said he “didn’t lose a minute of sleep” after the administration said it would endorse the temporary waiver of patents to bolster vaccine production in developing nations as a way to hasten an end to the pandemic.